2015 Plum Biology Annual Report: Net profit of 425 million Decreasing YoY 14.95%

On March 1,, Plum Bio released its 2015 annual reportThe company achieved operating income of RMB11,853 million, an increase of 20.15 percent over the same period last year, mainly due to increased sales volume and increased sales volumeNet profit attributable to shareholders of the parent company in 2015 was RMB425 million, a decrease of 14.95 percent compared to the same period in 2014In the main business, the domestic market achieved operating income of 8.890 billion yuan, up 28.49 percent year-on-year, while the foreign market realized operating income of RMB 2.910 billion, up 4.71% YoY, and achieved total revenue of RMB11.8 billionCQ7
Product sales, sales of small packages of MSG 29,000 tons, compared with the same period last year, 1600 tons less than the same period last year, large package MSG sales of 650,000 tons, an increase of 140,000 tons compared to 2014, small package OFMS sales decreased mainly due to the company to adjust sales strategy, slow down the attack on the commercial super and other terminal consumer market offensive intensity, production plans to large package customers to adjust dumpingAt the same time, due to the implementation of glutamate production line technical reform project, resulting in the process, technical level, extraction rate and fermentation acid rate have different degrees of growth, resulting in the actual production of glutamate is greater than the design capacityDuring the reporting period, the company sold 168,000 tons of Susine, an increase of 30,000 tons over 2014, due to increased production resulting in increased salesIn 2015, sales of 70% of lysine were 206,000 tons, an increase of 79,000 tons over 2014, and 98% of lysine content was 127,000 tons, an increase of 38,000 tons over 2014, resulting in increased sales due to increased productionCQ7
The main business sub-sector, sub-product, sub-region of the descriptionCQ71) company reporting period biofermentation industry operating income increased by 14.01 percent year-on-year, gross margin increased by 0.88 percentage points, the main reason for income growth is the release of Xinjiang plum production capacity and the main product sodium glutamate price increase, while sales prices led to a slight increase in gross marginCQ7
　　2) The company reported that the amino acid industry operating income increased by 26.53 percent year-on-year, gross margin decreased by 4.59 percentage points over the same period last year, the main reason for the increase in revenue growth is the increase in xinjiang plum lysine and other feed amino acid products sales, sucthane, lysine, huangrawgum and other products sales price decline, resulting in lower gross margin CQ7
　　3) During the company's reporting period, the fertilizer industry's operating income increased by 80.33 percent year-on-year, gross margin decreased by 6.14 percentage points from a year earlier, mainly due to the increase in fertilizer sales, while the fertilizer market competition, fertilizer product sales price decline led to a decrease in fertilizer gross margin CQ7
　　4) During the company's reporting period, the chemical industry operating income decreased by 18.69 percent year-on-year, gross margin decreased by 0.1 percentage points from a year earlier, the main reason for the decrease in revenue was the decrease in sales of liquid ammonia market, while the slight increase in the cost of liquid ammonia materials also led to a slight decrease in liquid ammonia gross margin CQ7
　　5) In the reporting period, the company's operating income in the biopharmaceutical industry increased by 243.42 percent year-on-year, and gross margin decreased by 6.27 percentage points from a year earlier CQ7
　　In the future, the company, on the one hand, through scientific and technological research and development and industrial mergers and acquisitions, will be corn deep processing industry "bigger, deep, real", through the extension of the industrial chain, the use of biological fermentation process of extract processing, production of some chemical products and pharmaceutical intermediates CQ7
　　On the other hand, as far as the current situation is concerned, the company still supports the strategy of low-cost and large customers, through the use of low-cost raw materials to reduce production costs, procurement companies through the local large coal enterprises signed a long-term procurement agreement to ensure the timely supply of coal, corn procurement company using collection and storage, market acquisition, procurement of state-owned grain banks and directly from farmers to buy and other ways of the combination of procurement model Sales and large customers to establish long-term cooperative relations, the establishment of peripheral libraries, save long-distance transportation costs, while with many large-scale terminal feed plants to establish comprehensive cooperative relations, and continue to develop new bulk customers, especially overseas customers CQ7
　　At the same time, continue to increase investment in scientific research, in the research and development of its own species, process development, product applications, the research and development department strive to do all the technical problems of the terminator, improve the extraction rate and product conversion rate, reduce the cost of tons of single consumption CQ7
　　In 2016, the company continued to adhere to the "full operation, create sharing" work guidelines, the introduction of world-renowned consulting companies, in strategic transformation, organizational change, operational excellence and other aspects of diagnosis, to assist the company to plan future development strategies CQ7
　　The company is in the suspension phase of the stock due to the planning of the issuance of shares to purchase assets After the completion of the transaction to purchase assets, the company's actual controller may change, and the company's strategy may be adjusted accordingly CQ7
　　On March 1, Plum Bio released its 2015 annual report The company achieved operating income of RMB11,853 million, an increase of 20.15 percent over the same period last year, mainly due to increased sales volume and increased sales volume Net profit attributable to shareholders of the parent company in 2015 was RMB425 million, a decrease of 14.95 percent compared to the same period in 2014 In the main business, the domestic market achieved operating income of 8.890 billion yuan, up 28.49 percent year-on-year, while the foreign market realized operating income of RMB 2.910 billion, up 4.71% YoY, and achieved total revenue of RMB11.8 billion CQ7
　　Product sales, sales of small packages of MSG 29,000 tons, compared with the same period last year, 1600 tons less than the same period last year, large package MSG sales of 650,000 tons, an increase of 140,000 tons compared to 2014, small package OFMS sales decreased mainly due to the company to adjust sales strategy, slow down the attack on the commercial super and other terminal consumer market offensive intensity, production plans to large package customers to adjust dumping At the same time, due to the implementation of glutamate production line technical reform project, resulting in the process, technical level, extraction rate and fermentation acid rate have different degrees of growth, resulting in the actual production of glutamate is greater than the design capacity During the reporting period, the company sold 168,000 tons of Susine, an increase of 30,000 tons over 2014, due to increased production resulting in increased sales In 2015, sales of 70% of lysine were 206,000 tons, an increase of 79,000 tons over 2014, and 98% of lysine content was 127,000 tons, an increase of 38,000 tons over 2014, resulting in increased sales due to increased production CQ7
　　The main business sub-sector, sub-product, sub-region of the description CQ7 1) company reporting period biofermentation industry operating income increased by 14.01 percent year-on-year, gross margin increased by 0.88 percentage points, the main reason for income growth is the release of Xinjiang plum production capacity and the main product sodium glutamate price increase, while sales prices led to a slight increase in gross margin CQ7
　　2) The company reported that the amino acid industry operating income increased by 26.53 percent year-on-year, gross margin decreased by 4.59 percentage points over the same period last year, the main reason for the increase in revenue growth is the increase in xinjiang plum lysine and other feed amino acid products sales, sucthane, lysine, huangrawgum and other products sales price decline, resulting in lower gross margin CQ7
　　3) During the company's reporting period, the fertilizer industry's operating income increased by 80.33 percent year-on-year, gross margin decreased by 6.14 percentage points from a year earlier, mainly due to the increase in fertilizer sales, while the fertilizer market competition, fertilizer product sales price decline led to a decrease in fertilizer gross margin CQ7
　　4) During the company's reporting period, the chemical industry operating income decreased by 18.69 percent year-on-year, gross margin decreased by 0.1 percentage points from a year earlier, the main reason for the decrease in revenue was the decrease in sales of liquid ammonia market, while the slight increase in the cost of liquid ammonia materials also led to a slight decrease in liquid ammonia gross margin CQ7
　　5) In the reporting period, the company's operating income in the biopharmaceutical industry increased by 243.42 percent year-on-year, and gross margin decreased by 6.27 percentage points from a year earlier CQ7
　　In the future, the company, on the one hand, through scientific and technological research and development and industrial mergers and acquisitions, will be corn deep processing industry "bigger, deep, real", through the extension of the industrial chain, the use of biological fermentation process of extract processing, production of some chemical products and pharmaceutical intermediates CQ7
　　On the other hand, as far as the current situation is concerned, the company still supports the strategy of low-cost and large customers, through the use of low-cost raw materials to reduce production costs, procurement companies through the local large coal enterprises signed a long-term procurement agreement to ensure the timely supply of coal, corn procurement company using collection and storage, market acquisition, procurement of state-owned grain banks and directly from farmers to buy and other ways of the combination of procurement model Sales and large customers to establish long-term cooperative relations, the establishment of peripheral libraries, save long-distance transportation costs, while with many large-scale terminal feed plants to establish comprehensive cooperative relations, and continue to develop new bulk customers, especially overseas customers CQ7
　　At the same time, continue to increase investment in scientific research, in the research and development of its own species, process development, product applications, the research and development department strive to do all the technical problems of the terminator, improve the extraction rate and product conversion rate, reduce the cost of tons of single consumption CQ7
　　In 2016, the company continued to adhere to the "full operation, create sharing" work guidelines, the introduction of world-renowned consulting companies, in strategic transformation, organizational change, operational excellence and other aspects of diagnosis, to assist the company to plan future development strategies CQ7
　　The company is in the suspension phase of the stock due to the planning of the issuance of shares to purchase assets After the completion of the transaction to purchase assets, the company's actual controller may change, and the company's strategy may be adjusted accordingly CQ7
Share it on feed